✦ LIBER ✦

Combination of photodynamic therapy with aspirin in human-derived lung adenocarcinoma cells affects proteasome activity and induces apoptosis

✍ Scribed by A. Chiaviello; I. Paciello; I. Postiglione; E. Crescenzi; G. Palumbo

Book ID: 108677992
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 765 KB
Volume: 43
Category: Article
ISSN: 0960-7722
DOI: 10.1111/j.1365-2184.2010.00698.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The synergistic anticancer effect of tro

The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells

✍ Kun-Huang Yan; Chih-Jung Yao; Hwan-You Chang; Gi-Ming Lai; Ann-Lii Cheng; Shuang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB

## Abstract Troglitazone (TGZ) is a synthetic thiazolidinedione drug belonging to a group of potent peroxisome proliferator‐activated receptor γ (PPARγ) agonists known to inhibit proliferation, alter cell cycle regulation, and induce apoptosis in various cancer cell types. TGZ is an oral anti‐type

Overexpression of the wild-type p53 gene

Overexpression of the wild-type p53 gene inhibits NF-κB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells

✍ Shao, Jianghua; Fujiwara, Toshiyoshi; Kadowaki, Yoshihiko; Fukazawa, Takuya; Wak 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 631 KB

Synergistic anti-proliferative and pro-a

Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells

✍ Tina Cascone; Maria Pia Morelli; Floriana Morgillo; Woo-Young Kim; Gabriella Rod 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 1 views

## Abstract The proteasome plays a pivotal role in the turnover of regulatory transduction proteins induced by activated cell membrane growth factor receptors. The epidermal growth factor receptor (EGFR) pathway is crucial in the development and progression of human epithelial cancers. Proteasome i

Synergistic anti-proliferative and pro-a

Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells

✍ Tina Cascone; Maria Pia Morelli; Floriana Morgillo; Woo-Young Kim; Gabriella Rod 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB 👁 1 views